Lysophosphatidic acid activates nuclear factor kappa B and induces proinlammatory gene expression in endothelial cells

Thrombosis and Haemostasis

Volumn 82, Issue 5, 1999, Pages 1532-1537

  Palmetshofer, Alois ^b   Robson, Simon C ^a   Nehls, Volker ^c  

^a HARVARD UNIVERSITY   (United States)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c NONE

Author keywords

Endothelial cells; Gene expression; Inflammation; Lysophosphatidic acid; Nuclear factor kappa B; Platelets; Transcription factor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GENISTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; LYSOPHOSPHATIDIC ACID; MEPACRINE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PERTUSSIS TOXIN; PHOSPHOLIPASE A2; RECOMBINANT TUMOR NECROSIS FACTOR; SURAMIN; THROMBOSPONDIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SWINE;

EID: 0032723655     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614867     Document Type: Article

References (34)

1. Jang IK, Lassila R, Fuster V. Atherogenesis and inflammation. Eur.Heart J 1993; 14 Suppl K: 2-6.
2. Savage CO, Cooke SP. The role of the endothelium in systemic vasculitis. J Autoimmun 1993; 6: 237-49.
3. Taubman MB. Gene induction in vessel wall injury. Thromb Haemost 1993; 70: 180-3.
4. Pober JS, Cotran RS. The role of endothelial cells in inflammation. Transplantation 1990; 50: 537-44.
5. Millan MT, Geczy C, Stuhlmeier KM, Goodman DJ, Ferran C, Bach FH. Human monocytes activate porcine endothelial cells, resulting in increased E-selectin, interleukin-8, monocyte chemotactic protein-1, and plasminogen activator inhibitor-type-1 expression. Transplantation 1997; 63: 421-9.
6. Introna M, Mantovani A. Early activation signals in endothelial cells. Stimulation by cytokines. Arterioscler Thromb Vasc Biol 1997; 17: 423-8.
7. Mantovani A, Sozzani S, Vecchi A, Introna M, Allavena P. Cytokine activation of endothelial cells: new molecules for an old paradigm. Thromb Haemost 1997; 78: 406-14.
8. Anrather J, Csizmadia V, Brostjan C, Soares MP, Bach FH, Winkler H. Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-kappa B. J Clin Invest 1997; 99: 763-72.
9. Eichholtz T, Jalink K, Fahrenfort I, Moolenaar WH. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem J 1993; 291: 677-80.
10. Panetti TS, Chen H, Misenheimer TM, Getzler SB, Mosher DF. Endothelial cell mitogenesis induced by LPA: inhibition by thrombospondin-1 and thrombospondin-2. J Lab Clin Med 1997; 129: 208-16.
11. Moolenaar WH, van CE. Growth factor-like action of lysophosphatidic acid: mitogenic signalling mediated by G proteins. Ciba Found Symp 1990; 150: 99-106.
12. Moolenaar WH. Lysophosphatidic acid signalling. Curr Opin Cell Biol 1995; 7: 203-10.
13. Tokumura A, Iimori M, Nishioka Y, Kitahara M, Sakashita M, Tanaka S. Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta. Am J Physiol 1994; 267: C204-10.
14. Tigyi G, Dyer DL, Miledi R. Lysophosphatidic acid possesses dual action in cell proliferation. Proc Natl Acad Sci USA 1994; 91: 1908-12.
15. van Corven EJ, van Rijswijk A, Jalink K, van-der Bend RL, van Blitterswijk WJ, Moolenaar WH. Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Dependence on acyl-chain length and inhibition by suramin. Biochem J 1992; 281: 163-9.
16. Xu Y, Shen Z, Wiper DW, et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA 1998; 280: 719-23.
17. Westermann AM, Havik E, Postma FR, et al. Malignant effusions contain lysophosphatidic acid (LPA)-like activity. Ann Oncol 1998; 9: 437-42.
18. van der Bend R, Brunner J, Jalink K, van Corven EJ, Moolenaar WH, van Blitterswijk WJ. Identification of a putative membrane receptor for the bioactive phospholipid, lysophosphatidic acid. EMBO 1992; 11: 2495-501.
19. Moolenaar WH, Kranenburg O, Postma FR, Zondag GC. Lysophosphatidic acid: G-protein signalling and cellular responses. Curr Opin Cell Biol 1997; 9: 168-73.
20. i-mediated activation of the Ras/MAP kinase pathway involves a 100 kDa tyrosine-phosphorylated Grb2 SH3 binding protein, but not Src nor Shc. EMBO J 1997; 16: 3097-105.
21. von Albertini MA, Palmetshofer A, Kaczmarek E, et al. Extracellular ATP and ADP activate transcription factor NF-kappa B and induce endothelial cell apoptosis. Biochem Biophys Res Commun 1998; 248: 822-9.
22. Anrather D, Millan MT, Palmetshofer A, et al. Thrombin activates nuclear factor-kappa B and potentiates endothelial cell activation by TNF. J Immunol 1997; 159: 5620-8.
23. Kravchenko VV, Pan Z, Han J, Herbert JM, Ulevitch RJ, Ye RD. Platelet-activating factor induces NF-kappa B activation through a G protein-coupled pathway. J Biol Chem 1995; 270: 14928-34.
24. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
25. Palmetshofer A, Galili U, Dalmasso AP, Robson SC, Bach FH. Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells: type II activation. Transplantation 1998; 65: 971-8.
26. Stuhlmeier KM, Kao JJ, Bach FH. Arachidonic acid influences proinflammatory gene induction by stabilizing the inhibitor-kappa B alpha/nuclear factor-kappa B (NF-kappa B) complex, thus suppressing the nuclear translocation of NF-kappa B. J Biol Chem 1997; 272: 24679-83.
27. 2 block TNF-induced activation of transcription factor nuclear factor-kappa B and expression of ICAM-1. J Immunol 1998; 161: 3421-30.
28. Moolenaar WH. Lysophosphatidic acid, a multifunctional phospholipid messenger. J Biol Chem 1995; 270: 12949-52.
29. Perona R, Montaner S, Saniger L, Sanchez-Perez I, Bravo R, Lacal JC. Activation of the nuclear factor-kappa B by Rho, CDC42, and Rac-1 proteins. Genes Dev 1997; 11: 463-75.
30. McLees A, Graham A, Malarkey K, Gould GW, Plevin R. Regulation of lysophosphatidic acid-stimulated tyrosine phosphorylation of mitogen-activated protein kinase by protein kinase C- and pertussis toxin-dependent pathways in the endothelial cell line EAhy 926. Biochem J 1995; 307: 743-8.
31. De Luca LG, Johnson DR, Whitley MZ, Collins T, Pober JS. cAMP and tumor necrosis factor competitively regulate transcriptional activation through and nuclear factor binding to the cAMP-responsive element/activating transcription factor element of the endothelial leukocyte adhesion molecule-1 (E-selectin) promoter. J Biol Chem 1994; 269: 19193-6.
32. Pober JS, Slowik MR, De LL, Ritchie AJ. Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1. J Immunol 1993; 150: 5114-23.
33. Stasek-JE J, Natarajan V, Garcia JG. Phosphatidic acid directly activates endothelial cell protein kinase C. Biochem Biophy Res Commun 1993; 191: 134-41.
34. Reiser CA, Lanz T, Hofmann F, Hofer G, Rupprecht HD, Goppelt-Struebe M. Lysophosphatidic acid-mediated signal-transduction pathways involved in the induction of the early-response genes prostaglandin G/H synthase-2 and egr-1: a critical role for the mitogen-activated protein kinase p38 and for rho proteins. Biochem J 1998; 330: 1107-4.